
Richard L. Raymond
Examiner (ID: 1923)
| Most Active Art Unit | 1209 |
| Art Unit(s) | 5611, 1209, 1616, 2899, 1206, 1624, 1611, 1201, 1205, 1621 |
| Total Applications | 4023 |
| Issued Applications | 3360 |
| Pending Applications | 236 |
| Abandoned Applications | 427 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1515621
[patent_doc_number] => RE037781
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors'
[patent_app_type] => E1
[patent_app_number] => 09/265808
[patent_app_country] => US
[patent_app_date] => 1999-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116101
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/037/RE037781.pdf
[firstpage_image] =>[orig_patent_app_number] => 09265808
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/265808 | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors | Mar 9, 1999 | Issued |
Array
(
[id] => 4156912
[patent_doc_number] => 06103754
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof'
[patent_app_type] => 1
[patent_app_number] => 9/264713
[patent_app_country] => US
[patent_app_date] => 1999-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10575
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103754.pdf
[firstpage_image] =>[orig_patent_app_number] => 264713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/264713 | Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof | Mar 8, 1999 | Issued |
Array
(
[id] => 4092358
[patent_doc_number] => 06133442
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/263034
[patent_app_country] => US
[patent_app_date] => 1999-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20790
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133442.pdf
[firstpage_image] =>[orig_patent_app_number] => 263034
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/263034 | Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists | Mar 4, 1999 | Issued |
Array
(
[id] => 4156271
[patent_doc_number] => 06107345
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Benzocyclobutane compounds'
[patent_app_type] => 1
[patent_app_number] => 9/261803
[patent_app_country] => US
[patent_app_date] => 1999-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6713
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 352
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/107/06107345.pdf
[firstpage_image] =>[orig_patent_app_number] => 261803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/261803 | Benzocyclobutane compounds | Mar 2, 1999 | Issued |
Array
(
[id] => 4219390
[patent_doc_number] => 06111102
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Processes for preparing sulfonylureas'
[patent_app_type] => 1
[patent_app_number] => 9/260885
[patent_app_country] => US
[patent_app_date] => 1999-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3612
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/111/06111102.pdf
[firstpage_image] =>[orig_patent_app_number] => 260885
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/260885 | Processes for preparing sulfonylureas | Mar 1, 1999 | Issued |
Array
(
[id] => 4408447
[patent_doc_number] => 06271377
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith'
[patent_app_type] => 1
[patent_app_number] => 9/257711
[patent_app_country] => US
[patent_app_date] => 1999-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32725
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1396
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271377.pdf
[firstpage_image] =>[orig_patent_app_number] => 257711
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/257711 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | Feb 24, 1999 | Issued |
Array
(
[id] => 1507841
[patent_doc_number] => 06440961
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them'
[patent_app_type] => B1
[patent_app_number] => 09/257104
[patent_app_country] => US
[patent_app_date] => 1999-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22545
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440961.pdf
[firstpage_image] =>[orig_patent_app_number] => 09257104
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/257104 | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them | Feb 23, 1999 | Issued |
Array
(
[id] => 4087957
[patent_doc_number] => 06162949
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Process for preparation of the pharmaceutically desired (S)-oxetine enantiomers'
[patent_app_type] => 1
[patent_app_number] => 9/255300
[patent_app_country] => US
[patent_app_date] => 1999-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2394
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162949.pdf
[firstpage_image] =>[orig_patent_app_number] => 255300
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/255300 | Process for preparation of the pharmaceutically desired (S)-oxetine enantiomers | Feb 21, 1999 | Issued |
Array
(
[id] => 4104508
[patent_doc_number] => 06051610
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-18
[patent_title] => 'Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases'
[patent_app_type] => 1
[patent_app_number] => 9/252433
[patent_app_country] => US
[patent_app_date] => 1999-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42412
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/051/06051610.pdf
[firstpage_image] =>[orig_patent_app_number] => 252433
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/252433 | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases | Feb 17, 1999 | Issued |
Array
(
[id] => 4108013
[patent_doc_number] => 06022871
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-08
[patent_title] => 'Oxadiazine derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/252541
[patent_app_country] => US
[patent_app_date] => 1999-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11831
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/022/06022871.pdf
[firstpage_image] =>[orig_patent_app_number] => 252541
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/252541 | Oxadiazine derivatives | Feb 17, 1999 | Issued |
Array
(
[id] => 4292129
[patent_doc_number] => 06235746
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Substituted 2-anilinopyrimidines useful as protein kinase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/249760
[patent_app_country] => US
[patent_app_date] => 1999-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27928
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235746.pdf
[firstpage_image] =>[orig_patent_app_number] => 249760
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/249760 | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | Feb 15, 1999 | Issued |
Array
(
[id] => 4190360
[patent_doc_number] => 06153609
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Arylsulfonylamino hydroxamic acid derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/242504
[patent_app_country] => US
[patent_app_date] => 1999-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12383
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1916
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153609.pdf
[firstpage_image] =>[orig_patent_app_number] => 242504
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242504 | Arylsulfonylamino hydroxamic acid derivatives | Feb 15, 1999 | Issued |
Array
(
[id] => 1289562
[patent_doc_number] => RE038257
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2003-09-23
[patent_title] => 'Piperdine derivatives and hypotensives containing the same'
[patent_app_type] => E1
[patent_app_number] => 09/248236
[patent_app_country] => US
[patent_app_date] => 1999-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11088
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038257.pdf
[firstpage_image] =>[orig_patent_app_number] => 09248236
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/248236 | Piperdine derivatives and hypotensives containing the same | Feb 9, 1999 | Issued |
Array
(
[id] => 4401715
[patent_doc_number] => 06171603
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Bioaromatic amido compounds and pharmaceutical/cosmetic compositions comprised thereof'
[patent_app_type] => 1
[patent_app_number] => 9/246715
[patent_app_country] => US
[patent_app_date] => 1999-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9029
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 768
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171603.pdf
[firstpage_image] =>[orig_patent_app_number] => 246715
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/246715 | Bioaromatic amido compounds and pharmaceutical/cosmetic compositions comprised thereof | Feb 8, 1999 | Issued |
Array
(
[id] => 4234952
[patent_doc_number] => 06117874
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-12
[patent_title] => 'Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B.sub.4 (LTB.sub.4 ) antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/241209
[patent_app_country] => US
[patent_app_date] => 1999-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14523
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 626
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/117/06117874.pdf
[firstpage_image] =>[orig_patent_app_number] => 241209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/241209 | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B.sub.4 (LTB.sub.4 ) antagonists | Jan 31, 1999 | Issued |
Array
(
[id] => 4096955
[patent_doc_number] => 06096755
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'N-substituted azabicycloalkane derivatives, their preparation and use'
[patent_app_type] => 1
[patent_app_number] => 9/241299
[patent_app_country] => US
[patent_app_date] => 1999-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9989
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 344
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096755.pdf
[firstpage_image] =>[orig_patent_app_number] => 241299
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/241299 | N-substituted azabicycloalkane derivatives, their preparation and use | Jan 31, 1999 | Issued |
Array
(
[id] => 4359455
[patent_doc_number] => 06174923
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Use of ethynyl alanine amino diol compounds for treatment of renin-mediated disorders'
[patent_app_type] => 1
[patent_app_number] => 9/239493
[patent_app_country] => US
[patent_app_date] => 1999-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10890
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 399
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/174/06174923.pdf
[firstpage_image] =>[orig_patent_app_number] => 239493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/239493 | Use of ethynyl alanine amino diol compounds for treatment of renin-mediated disorders | Jan 27, 1999 | Issued |
Array
(
[id] => 4192805
[patent_doc_number] => 06043233
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs'
[patent_app_type] => 1
[patent_app_number] => 9/235804
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17977
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043233.pdf
[firstpage_image] =>[orig_patent_app_number] => 235804
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235804 | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs | Jan 21, 1999 | Issued |
Array
(
[id] => 4210149
[patent_doc_number] => 06028197
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Dibenzo[a,g]quinolizinium derivatives and the salts thereof'
[patent_app_type] => 1
[patent_app_number] => 9/235482
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18827
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/028/06028197.pdf
[firstpage_image] =>[orig_patent_app_number] => 235482
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235482 | Dibenzo[a,g]quinolizinium derivatives and the salts thereof | Jan 21, 1999 | Issued |
| 09/235271 | NOVEL SULFONAMIDE DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND AS INHIBITORS OF CELL ADHESION | Jan 21, 1999 | Abandoned |